● Tenon Medical shares have swung sharply following mixed Q2 results, most recently closing at $7.07, down 38.04%.
● TROOPS shares have fallen sharply, most recently closing at $2.06, down 9.65%, down sharply on a year-to-date and one-month basis despite having risen more than 200% over theTrailing Twelve Monthsat one point.
● Rising DragonAcquisitionhas continued giving back gains from an April surge above $21, most recently closing at $6.65, down 24.26%.
● Sionna Therapeutics shares have fallen sharply, most recently closing at $5.52, down 11.68%, after topline data from two development programs.
● Profusa shares have fallen sharply, most recently closing at $7.57, down 44.22%, after the company disclosed a non-binding term sheet to acquire a privately held diagnostics and toxicology testing business.
● QumulusAI shares have fallen sharply, most recently closing at $5.36, down 9.31%, near the bottom of its post-listing trading range.
● Moderna shares have fallen sharply, most recently closing at $133.32, down 23.55%, extending aReversalfrom a historic melanoma-data rally.
● Olenox Industries shares have fallen sharply, most recently closing at $2.10, down 12.86%, deep within a 52-week range of roughly $2.10 to $157.12, with a marketCapitalizationof about $3.5 million.
● Onterris shares have fallen sharply, most recently closing at $14.66, down 11.79%, after Q2Revenueof $186.7 million missed estimates by about 6.3% and fell roughly 20.4% year over year.
● Lexicon Pharmaceuticals shares have fallen sharply, most recently closing at $2.18, down 9.54%, with no confirmed company-specific catalyst identified for the decline.